Polycystic kidney disease complicated with cystic infection caused by multi-drug resistant Klebsiella pneumoniae: a case report and literature review

doi:10.3877/cma.j.issn.1674-0785.2023.08.014

Abstract

Abstract:

Cyst infection, a common complication in patients with polycystic kidney disease, is difficult to control, prone to recurrence, and even life-threatening. In particular, cyst infections caused by drug-resistant bacteria are significantly more difficult to treat. In this paper, we report a case of polycystic kidney disease complicated with cyst infection with bacteremia caused by carbapenem-resistant Klebsiella pneumoniae. Satisfactory efficacy was achieved by using antibacterial drugs combined with internal drainage. This case report aims to provide some ideas for the clinical diagnosis and treatment of this condition.

Key words: Polycystic kidney disease, Urinary tract infections, Cyst infections, Klebsiella pneumoniae, Multi-drug resistance

Jingjing Li, Lei Zhai, Haiping Zhao, Bo Zheng. Polycystic kidney disease complicated with cystic infection caused by multi-drug resistant Klebsiella pneumoniae: a case report and literature review[J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(08): 920-923.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlcyszz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0785.2023.08.014

https://zhlcyszz.cma-cmc.com.cn/EN/Y2023/V17/I08/920

Figures/Tables 2

References 22

1	Zhao N, Cao J, Xu J, et al. Targeting RNA with Next- and third-generation sequencing improves pathogen identification in clinical samples [J]. Adv Sci (Weinh), 2021, 8(23): e2102593.
2	袁莹, 杨颖.. 多粘菌素B和E:如何选择 [J]. 中国感染控制杂志, 2017, 16(7): 677-682.
3	Chebib F T, Torres V E. Autosomal dominant polycystic kidney disease: Core curriculum 2016 [J]. Am J Kidney Dis, 2016, 67(5): 792-810.
4	Chapman A B, Guay-Woodford L M, Grantham J J, et al. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The consortium for radiologic imaging studies of polycystic kidney disease (CRISP) cohort [J]. Kidney Int, 2003, 64(3): 1035-1045.
5	Ong A C, Devuyst O, Knebelmann B, et al. Autosomal dominant polycystic kidney disease: the changing face of clinical management [J]. Lancet, 2015, 385(9981): 1993-2002.
6	Sallée M, Rafat C, Zahar J R, et al. Cyst infections in patients with autosomal dominant polycystic kidney disease [J]. Clin J Am Soc Nephrol, 2009, 4(7): 1183-1189.
7	Rizk D, Chapman A B. Cystic and inherited kidney diseases [J]. Am J Kidney Dis, 2003, 42(6): 1305-1317.
8	Bleeker-Rovers C P, de Sevaux R G, van Hamersvelt H W, et al. Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease [J]. Am J Kidney Dis, 2003, 41(6): E18-E21.
9	Migali G, Annet L, Lonneux M, et al. Renal cyst infection in autosomal dominant polycystic kidney disease [J]. Nephrol Dial Transplant, 2008, 23(1): 404-405.
10	Myint K S, Merchant R A. Is this just another urinary tract infection? [J]. J Am Geriatr Soc, 2015, 63(4): 823-824.
11	Ubee S S, Mcglynn L, Fordham M. Emphysematous pyelonephritis [J]. BJU Int, 2011, 107(9): 1474-1478.
12	孙艳, 多丽波. 耐碳青霉烯类肠杆菌科细菌耐药机制及实验室检测研究进展 [J]. 国际检验医学杂志, 2020, 41(16): 2011-2016.
13	杨雪, 刘琳, 张湘燕. 耐碳青霉烯类肺炎克雷伯杆菌的耐药机制及治疗策略研究进展 [J]. 医学研究生学报, 2018, 31(4): 430-434.
14	Suwabe T, Araoka H, Ubara Y, et al. Cyst infection in autosomal dominant polycystic kidney disease: causative microorganisms and susceptibility to lipid-soluble antibiotics [J]. Eur J Clin Microbiol Infect Dis, 2015, 34(7): 1369-1379.
15	Hiyama L, Tang A, Miller L G. Levofloxacin penetration into a renal cyst in a patient with autosomal dominant polycystic kidney disease [J]. Am J Kidney Dis, 2006, 47(1): e9-e13.
16	龙晓琴, 方丽. 耐碳青霉烯类肺炎克雷伯杆菌感染的研究进展 [J]. 疑难病杂志, 2021, 20(12): 1282-1286.
17	Mazuski J E, Gasink L B, Armstrong J, et al. Efficacy and safety of ceftazidime-avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infection: results from a randomized, controlled, double-blind, phase 3 program [J]. Clin Infect Dis, 2016, 62(11): 1380-1389.
18	王琴, 邹自英, 谭积善, 等. 头孢他啶-阿维巴坦在耐碳青霉烯类肺炎克雷伯菌中的药物敏感性分析 [J]. 检验医学与临床, 2019, 16(6): 802-804.
19	Zhang J, Yu L, Fu Y, et al. Tigecycline in combination with other antibiotics against clinical isolates of carbapenem-resistant Klebsiella pneumoniae in vitro [J]. Ann Palliat Med, 2019, 8(5): 622-631.
20	Wang J, Pan Y, Shen J, et al. The efficacy and safety of tigecycline for the treatment of bloodstream infections: a systematic review and meta-analysis [J]. Ann Clin Microbiol Antimicrob, 2017, 16(1): 24.
21	Lantinga M A, Casteleijn N F, Geudens A, et al. Management of renal cyst infection in patients with autosomal dominant polycystic kidney disease: A systematic review [J]. Nephrology Dialysis Transplantation, 2016: v452.
22	Suwabe T. Cyst infection in autosomal dominant polycystic kidney disease: our experience at Toranomon Hospital and future issues [J]. Clin Exp Nephrol, 2020, 24(9): 748-761.

抗生素名称	MIC（ug/ml）	敏感度	抗生素名称	MIC（ug/ml）	敏感度
复方新诺明	≤20	S	头孢吡肟	≤32	R
阿米卡星	≤2	S	头孢西丁	≤64	R
头孢哌酮/舒巴坦	≤64	R	头孢呋辛酯	≤64	R
头孢他啶	≤64	R	亚胺培南	≤16	R
头孢呋辛钠	≤64	R	左氧氟沙星	≤8	R
头孢曲松	≤64	R	厄他培南	≤8	R
阿莫西林/克拉维酸	≤32	R	哌拉西林/他唑巴坦	≤128	R

抗生素名称	MIC（ug/ml）	敏感度	抗生素名称	MIC（ug/ml）	敏感度
复方新诺明	≤20	S	头孢吡肟	≤32	R
阿米卡星	≤2	S	头孢西丁	≤64	R
头孢哌酮/舒巴坦	≤64	R	头孢呋辛酯	≤64	R
头孢他啶	≤64	R	亚胺培南	≤16	R
头孢呋辛钠	≤64	R	左氧氟沙星	≤8	R
头孢曲松	≤64	R	厄他培南	≤8	R
阿莫西林/克拉维酸	≤32	R	哌拉西林/他唑巴坦	≤128	R

[1]	Kankan Gao, Huamin Zhong, Yongqiang Xie, Qiulian Deng, Fei Gao, Jielin Wang, Yan Long. Female genitourinary tract Mycoplasma infection and its resistance rate [J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2022, 18(05): 569-576.
[2]	Xiaoqing Zhong, Kang Liao, Xin Wang, Xunhua Zheng, Yagui Qiu, Yuanwen Xu, Guangran Li, Dihua Zhang, Fengxian Huang, Xiao Yang. Analysis of pathogenic bacteria and drug resistance of urinary tract infection in outpatient women [J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2022, 18(02): 185-191.
[3]	Lini Chen, Lili Luo, Deyuan Li, Zhongqiang Liu, Lina Qiao. Clinical characteristics of children with urosepsis [J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2019, 15(03): 292-299.
[4]	Wenlu Hang, Yongliang Du, Zhanjie Li, Haiquan Li, Jie Zhao, Yu Zhang. Carbapenem-resistant Klebsiella pneumoniae nosocomial infection in a patient with immunodeficiency [J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2022, 16(03): 205-209.
[5]	Ziyan Shen, Shaoqing Lin, Xingran Du, Shuidi Zhao, Ganzhu Feng. Clinical characteristics and prognostic risk factors of hospital acquired Klebsiella pneumoniae bloodstream infection [J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2020, 14(03): 198-205.
[6]	Ciyan Chen, Yan Du. Progress on hypervirulent Klebsiella pneumoniae [J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2019, 13(02): 89-92.
[7]	Haochong Hu, Yiting Liu, Jiayu Guo, Jilin Zou, Zhongbao Chen, Jiangqiao Zhou, Tao Qiu. Treatment and analysis of carbapenem-resistant Klebsiella pneumoniae infection after renal transplantation [J]. Chinese Journal of Transplantation(Electronic Edition), 2023, 17(04): 246-249.
[8]	Wenlei Li, Jushan Wu, Zhe Jia, Na Pan, Wenyue Wu, Binwei Duan, Guangming Li. Risk factors of carbapenem-resistant Klebsiella pneumoniae infection after liver transplantation [J]. Chinese Journal of Transplantation(Electronic Edition), 2021, 15(06): 347-352.
[9]	jinlong Qu, Jun Guan, Zhaofen Lin. Two cases report of renal allograft artery rupture and hemorrhage caused by Klebsiella pneumoniae infection after renal transplantation [J]. Chinese Journal of Transplantation(Electronic Edition), 2018, 12(01): 39-41.
[10]	Huaxiang Wang, Fengfeng Xu, Ruisheng Ke, Fang Yang, Qiucheng Cai, Jianyong Liu, Xinghua Huang, Yi Jiang. Analysis of early infection and bacterial drug resistance in liver transplant patients from organ donation after death [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2019, 08(06): 507-511.
[11]	He Sun, Chunfeng He, Xiaodong Wu, Huize Han, Yi Shi, Qiang Li. Efficacy and safety analysis of Ceftazidime-Avibatam in carbapene-resistant Klebsiella pneumoniae infected patients with septic shock [J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2021, 07(01): 76-80.
[12]	Weiqi Su, Wei Luo, Xiaoyan You. Phenotypic characteristics and drug resistance of Klebsiella pneumoniae [J]. Chinese Journal of Clinicians(Electronic Edition), 2020, 14(09): 669-673.
[13]	Huiling Liang, Chao Han, Linying Zheng, Zhen Huang, Donghua Gao. Preliminary study on bacteriostatic-effect of Qiaoqinqingfei on Klebsiella pneumoniae and Staphylococcus aureus [J]. Chinese Journal of Clinical Laboratory Management(Electronic Edition), 2022, 10(01): 13-16.
[14]	Li Liu, Meijie Jiang, Zhongmei Zhou. Analysis of drug resistance of Klebsiella pneumonia isolated from different specimens in hospital [J]. Chinese Journal of Clinical Laboratory Management(Electronic Edition), 2019, 07(01): 31-34.
[15]	Li Liu, Lin Li, Meijie Jiang. Mechanism of aminoglycoside resistance and molecular epidemiology of amikacin-resistant Klebsiella pneumoniae in hospital [J]. Chinese Journal of Clinical Laboratory Management(Electronic Edition), 2018, 06(01): 39-42.

Please choose a citation manager

Content to export